Champions Oncology
CSBR
CSBR
32 hedge funds and large institutions have $49.8M invested in Champions Oncology in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.54%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
3
Increased
6
Reduced
6
Closed
–
Calls
$2.24M
Puts
–
Net Calls
+$2.24M
Net Calls Change
+$415K
Top Buyers
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$1.32M |
| 2 |
2
Morgan Stanley
New York
|
$43K |
| 3 |
3
Millennium Management
New York
|
$425K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$16K |
| 5 |
5
Ameriprise
Minneapolis,
Minnesota
|
$681K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| $16K | -$8.18K | -1,022 | -34% |
|
|
TCWM
27
Total Clarity Wealth Management
St. Charles,
Illinois
| $7K | +$7K | +937 | New |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|